249 related articles for article (PubMed ID: 30288660)
61. Physcion 8-O-β-glucopyranoside ameliorates liver fibrosis through inflammation inhibition by regulating SIRT3-mediated NF-κB P65 nuclear expression.
Chen C; Gu J; Wang J; Wu Y; Yang A; Chen T; Zhou T; Liu Z
Int Immunopharmacol; 2021 Jan; 90():107206. PubMed ID: 33246826
[TBL] [Abstract][Full Text] [Related]
62. Codonopis bulleynana Forest ex Diels (cbFeD) effectively attenuates hepatic fibrosis in CCl
Li X; Xing Y; Mao D; Ying L; Luan Y; Xu M; Wang H; Li C; Li Y; Zheng S; Li Z; Hu J; Li Z; Wang H; Luan Y
Biomed Pharmacother; 2021 Jan; 133():110960. PubMed ID: 33197763
[TBL] [Abstract][Full Text] [Related]
63. Soluble Guanylyl Cyclase Activator BI 685509 Reduces Portal Hypertension and Portosystemic Shunting in a Rat Thioacetamide-Induced Cirrhosis Model.
Jones AK; Chen H; Ng KJ; Villalona J; McHugh M; Zeveleva S; Wilks J; Brilisauer K; Bretschneider T; Qian HS; Fryer RM
J Pharmacol Exp Ther; 2023 Jul; 386(1):70-79. PubMed ID: 37230799
[TBL] [Abstract][Full Text] [Related]
64. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.
Abramovitch S; Dahan-Bachar L; Sharvit E; Weisman Y; Ben Tov A; Brazowski E; Reif S
Gut; 2011 Dec; 60(12):1728-37. PubMed ID: 21816960
[TBL] [Abstract][Full Text] [Related]
65. Stevia rebaudiana tea prevents experimental cirrhosis via regulation of NF-κB, Nrf2, transforming growth factor beta, Smad7, and hepatic stellate cell activation.
Ramos-Tovar E; Flores-Beltrán RE; Galindo-Gómez S; Vera-Aguilar E; Diaz-Ruiz A; Montes S; Camacho J; Tsutsumi V; Muriel P
Phytother Res; 2018 Dec; 32(12):2568-2576. PubMed ID: 30251285
[TBL] [Abstract][Full Text] [Related]
66. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
67. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues.
Hernández-Gea V; Ghiassi-Nejad Z; Rozenfeld R; Gordon R; Fiel MI; Yue Z; Czaja MJ; Friedman SL
Gastroenterology; 2012 Apr; 142(4):938-46. PubMed ID: 22240484
[TBL] [Abstract][Full Text] [Related]
68. Capsaicin attenuates liver fibrosis by targeting Notch signaling to inhibit TNF-α secretion from M1 macrophages.
Sheng J; Zhang B; Chen Y; Yu F
Immunopharmacol Immunotoxicol; 2020 Dec; 42(6):556-563. PubMed ID: 32811220
[TBL] [Abstract][Full Text] [Related]
69. Role of growth factor receptor-bound 2 in CCl
Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y
Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656
[TBL] [Abstract][Full Text] [Related]
70. Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells.
Wang X; Ikejima K; Kon K; Arai K; Aoyama T; Okumura K; Abe W; Sato N; Watanabe S
J Hepatol; 2011 Aug; 55(2):379-87. PubMed ID: 21168456
[TBL] [Abstract][Full Text] [Related]
71. DNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis.
Yang JJ; She Q; Yang Y; Tao H; Li J
Toxicol Lett; 2018 Oct; 295():325-334. PubMed ID: 30010033
[TBL] [Abstract][Full Text] [Related]
72. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA
Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
[TBL] [Abstract][Full Text] [Related]
73. Hydroxysafflor yellow A attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting ERK5 signaling.
Zhang YB; Dong HY; Zhao XM; Fan L; Zou Y; Zhang C; Li G; Liu JC; Niu YC
Am J Chin Med; 2012; 40(3):481-94. PubMed ID: 22745065
[TBL] [Abstract][Full Text] [Related]
74. Preventive effects of a fractioned polysaccharide from a traditional Chinese herbal medical formula (Yu Ping Feng San) on carbon tetrachloride-induced hepatic fibrosis.
Wang JJ; Li J; Shi L; Lv XW; Cheng WM; Chen YY
J Pharm Pharmacol; 2010 Jul; 62(7):935-42. PubMed ID: 20636883
[TBL] [Abstract][Full Text] [Related]
75. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
76. HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects.
Klein S; Van Beuge MM; Granzow M; Beljaars L; Schierwagen R; Kilic S; Heidari I; Huss S; Sauerbruch T; Poelstra K; Trebicka J
J Hepatol; 2012 Dec; 57(6):1220-7. PubMed ID: 22878469
[TBL] [Abstract][Full Text] [Related]
77. Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease.
Boyer-Diaz Z; Aristu-Zabalza P; Andrés-Rozas M; Robert C; Ortega-Ribera M; Fernández-Iglesias A; Broqua P; Junien JL; Wettstein G; Bosch J; Gracia-Sancho J
J Hepatol; 2021 May; 74(5):1188-1199. PubMed ID: 33278455
[TBL] [Abstract][Full Text] [Related]
78. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model.
Shim SG; Jun DW; Kim EK; Saeed WK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
J Gastroenterol Hepatol; 2013 Dec; 28(12):1877-84. PubMed ID: 23808892
[TBL] [Abstract][Full Text] [Related]
79. Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation.
Liu YW; Chiu YT; Fu SL; Huang YT
J Biomed Sci; 2015 Aug; 22(1):63. PubMed ID: 26231226
[TBL] [Abstract][Full Text] [Related]
80. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Fan W; Liu T; Chen W; Hammad S; Longerich T; Hausser I; Fu Y; Li N; He Y; Liu C; Zhang Y; Lian Q; Zhao X; Yan C; Li L; Yi C; Ling Z; Ma L; Zhao X; Xu H; Wang P; Cong M; You H; Liu Z; Wang Y; Chen J; Li D; Hui L; Dooley S; Hou J; Jia J; Sun B
Gastroenterology; 2019 Nov; 157(5):1352-1367.e13. PubMed ID: 31362006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
